Mesoblast
MESO
#4320
Rank
A$3.67 B
Marketcap
A$28.54
Share price
1.55%
Change (1 day)
64.06%
Change (1 year)

Mesoblast (MESO) - Total assets

Total assets on the balance sheet as of June 2025 : A$1.17 Billion

According to Mesoblast 's latest financial reports the company's total assets are A$1.17 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Mesoblast - Total assets on balance sheet (from 2012 to 2025)

Total assets by year

Year Total assets Change
2024-06-30A$1.00 B-0.19%
2023-06-30A$1.00 B4.64%
2022-06-30A$0.95 B-3.35%
2021-06-30A$0.99 B-6.55%
2020-06-30A$1.06 B14.47%
2019-06-30A$0.92 B-0.73%
2018-06-30A$0.93 B9.52%
2017-06-30A$0.85 B-7%
2016-06-30A$0.91 B-9.62%
2015-06-30A$1.01 B6.54%
2014-06-30A$0.95 B-1.48%
2013-06-30A$0.96 B37.62%
2012-06-30A$0.70 B-1.22%
2011-06-30A$0.71 B1426.48%
2010-06-30A$46.65 M39.91%
2009-06-30A$33.34 M14.76%
2008-06-30A$29.05 M15.84%
2007-06-30A$25.08 M12.8%
2006-06-30A$22.23 M-20.96%
2005-06-30A$28.13 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
NRC Health
NRC
A$0.20 B-82.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Nymox Pharmaceutical
NYMX
A$0.4 M-99.97% Bahamas